Drug Discovery 2022: driving the next life science revolution

Prof Berend Snijder

Prof Berend Snijder
Prof Berend Snijder
Assistant Professor
ETH Zurich
Delegate / Speaker

Presentations at Drug Discovery 2022: driving the next life science revolution

Profile of Prof Berend Snijder

Berend Snijder is Assistant Professor of Molecular Systems Biology at the ETH Zurich in Switzerland, supported among others by the Swiss National Science Foundation, an ERC Starting Grant, and public/private partnerships with pharmaceutical companies. Berend received his MSc degree in Biomedical Sciences with honors from the University of Amsterdam, and performed his PhD studies working on image-based screening and cell-to-cell variability analyses in the lab of Lucas Pelkmans at the IMSB, ETH Zurich, for which he was awarded the ETH Medal. For his postdoctoral studies he joined the lab of Giulio Superti-Furga at the Center for Molecular Medicine in Vienna, where he received a Young Investigator Award from the Austrian Society for Hematology and Medical Oncology, and co-founded the biotech startup Allcyte GmbH. The Snijder lab currently develops Pharmacoscopy, a method to measure ex vivo drug responses in patient biopsies using automated microscopy, image analysis and deep learning, with the goal to improve treatment selection in cancer and gain systems-level insights into why patients respond differently to medications. Please see https://snijderlab.org for more information.


Please login to send a Private Message

Hosted By


The European Laboratory Research & Innovation Group Our Vision : To provide outstanding, leading edge knowledge to the life sciences community on an open access basis

Get the App

Get this event information on your mobile by
going to the appstore or google play and search for 'elrig'